Published in Cancer Res on March 01, 2008
Genome-wide association study identifies five new schizophrenia loci. Nat Genet (2011) 9.07
Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nat Rev Genet (2012) 5.99
MicroRNA and cancer--focus on apoptosis. J Cell Mol Med (2009) 2.44
MicroRNA signatures differentiate melanoma subtypes. Cell Cycle (2011) 1.99
Dedifferentiation and proliferation of mammalian cardiomyocytes. PLoS One (2010) 1.89
Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis. Cancer Res (2010) 1.88
The role of miR-18b in MDM2-p53 pathway signaling and melanoma progression. J Natl Cancer Inst (2013) 1.76
MicroRNA profiling and head and neck cancer. Comp Funct Genomics (2009) 1.68
Melanoma MicroRNA signature predicts post-recurrence survival. Clin Cancer Res (2010) 1.59
The regulation of miRNA-211 expression and its role in melanoma cell invasiveness. PLoS One (2010) 1.55
Role of miRNAs in the progression of malignant melanoma. Br J Cancer (2009) 1.41
Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer. Carcinogenesis (2012) 1.32
Retracted MicroRNA-340-mediated degradation of microphthalmia-associated transcription factor mRNA is inhibited by the coding region determinant-binding protein. J Biol Chem (2010) 1.32
miR-137 is frequently down-regulated in gastric cancer and is a negative regulator of Cdc42. Dig Dis Sci (2011) 1.24
MicroRNA Deregulations in Head and Neck Squamous Cell Carcinomas. J Oral Maxillofac Res (2013) 1.22
miR-148 regulates Mitf in melanoma cells. PLoS One (2010) 1.21
Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies. J Transl Med (2010) 1.17
Microphthalmia-associated transcription factor in melanoma development and MAP-kinase pathway targeted therapy. Pigment Cell Melanoma Res (2015) 1.12
Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma. Clin Cancer Res (2009) 1.11
miR-193b Regulates Mcl-1 in Melanoma. Am J Pathol (2011) 1.09
MicroRNA-137 targets carboxyl-terminal binding protein 1 in melanoma cell lines. Int J Biol Sci (2011) 1.06
MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy. Carcinogenesis (2012) 1.06
Coregulation of transcription factors and microRNAs in human transcriptional regulatory network. BMC Bioinformatics (2011) 1.05
Schizophrenia miR-137 locus risk genotype is associated with dorsolateral prefrontal cortex hyperactivation. Biol Psychiatry (2013) 1.05
Intrinsic expression of host genes and intronic miRNAs in prostate carcinoma cells. Cancer Cell Int (2009) 1.04
Comprehensive analysis of human microRNA target networks. BioData Min (2011) 1.04
miR-200c regulates FGFR-dependent epithelial proliferation via Vldlr during submandibular gland branching morphogenesis. Development (2011) 1.04
Decoding melanoma metastasis. Cancers (Basel) (2010) 1.02
Transcriptional targets of the schizophrenia risk gene MIR137. Transl Psychiatry (2014) 1.02
Coat color determination by miR-137 mediated down-regulation of microphthalmia-associated transcription factor in a mouse model. RNA (2012) 1.00
MicroRNAs in skin and wound healing. Physiol Genomics (2010) 1.00
Epigenetic regulation in human melanoma: past and future. Epigenetics (2015) 0.98
MITF in melanoma: mechanisms behind its expression and activity. Cell Mol Life Sci (2014) 0.97
Potential Impact of miR-137 and Its Targets in Schizophrenia. Front Genet (2013) 0.96
Identification of microRNA activity by Targets' Reverse EXpression. Bioinformatics (2009) 0.95
MIR137 variants identified in psychiatric patients affect synaptogenesis and neuronal transmission gene sets. Mol Psychiatry (2014) 0.94
Epigenetic regulation of microRNA genes and the role of miR-34b in cell invasion and motility in human melanoma. PLoS One (2011) 0.94
Transcription factor SOX9 plays a key role in the regulation of visual cycle gene expression in the retinal pigment epithelium. J Biol Chem (2014) 0.92
Searching for the 'melano-miRs': miR-214 drives melanoma metastasis. EMBO J (2011) 0.92
microRNA-137 modulates pancreatic cancer cells tumor growth, invasion and sensitivity to chemotherapy. Int J Clin Exp Pathol (2014) 0.92
Pro-survival role of MITF in melanoma. J Invest Dermatol (2014) 0.91
miR-98 suppresses melanoma metastasis through a negative feedback loop with its target gene IL-6. Exp Mol Med (2014) 0.90
miR-137 regulates the constitutive androstane receptor and modulates doxorubicin sensitivity in parental and doxorubicin-resistant neuroblastoma cells. Oncogene (2013) 0.90
Regulation of microRNA biosynthesis and expression in 2102Ep embryonal carcinoma stem cells is mirrored in ovarian serous adenocarcinoma patients. J Ovarian Res (2009) 0.90
The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanoma. Arch Biochem Biophys (2014) 0.89
Biochemistry of epidermal stem cells. Biochim Biophys Acta (2012) 0.88
Identification and characterization of microRNAs in white and brown alpaca skin. BMC Genomics (2012) 0.87
Genome-wide methylated CpG island profiles of melanoma cells reveal a melanoma coregulation network. Sci Rep (2013) 0.87
Integrative analysis of somatic mutations altering microRNA targeting in cancer genomes. PLoS One (2012) 0.84
MicroRNA in Melanoma. Ochsner J (2010) 0.84
miR in melanoma development: miRNAs and acquired hallmarks of cancer in melanoma. Physiol Genomics (2013) 0.83
Overexpression of the miR-34 family suppresses invasive growth of malignant melanoma with the wild-type p53 gene. Exp Ther Med (2012) 0.82
Alterations of MicroRNAs in Solid Cancers and Their Prognostic Value. Cancers (Basel) (2010) 0.82
Polymorphisms in microRNA target sites of forkhead box O genes are associated with hepatocellular carcinoma. PLoS One (2015) 0.82
MicroRNA-340-mediated degradation of microphthalmia-associated transcription factor (MITF) mRNA is inhibited by coding region determinant-binding protein (CRD-BP). J Biol Chem (2014) 0.82
Characterization of a REST-Regulated Internal Promoter in the Schizophrenia Genome-Wide Associated Gene MIR137. Schizophr Bull (2014) 0.80
Genetics of uveal melanoma and cutaneous melanoma: two of a kind? Dermatol Res Pract (2010) 0.80
Long non-coding RNA GAS5 inhibits tumorigenesis via miR-137 in melanoma. Am J Transl Res (2017) 0.80
Non-targeting siRNA induces NPGPx expression to cooperate with exoribonuclease XRN2 for releasing the stress. Nucleic Acids Res (2011) 0.79
Genomic features and computational identification of human microRNAs under long-range developmental regulation. BMC Genomics (2011) 0.78
MicroRNA-218 inhibits melanogenesis by directly suppressing microphthalmia-associated transcription factor expression. RNA Biol (2014) 0.78
miRVaS: a tool to predict the impact of genetic variants on miRNAs. Nucleic Acids Res (2015) 0.78
MicroRNAs in melanoma development and resistance to target therapy. Oncotarget (2017) 0.78
The Roles of Two miRNAs in Regulating the Immune Response of Sea Cucumber. Genetics (2015) 0.77
miRNAs and Melanoma: How Are They Connected? Dermatol Res Pract (2011) 0.77
microRNA-155, induced by interleukin-1ß, represses the expression of microphthalmia-associated transcription factor (MITF-M) in melanoma cells. PLoS One (2015) 0.76
Prognostic parameters for the primary care of melanoma patients: what is really risky in melanoma? J Skin Cancer (2011) 0.76
Methylation-mediated molecular dysregulation in clinical oral malignancy. J Oncol (2012) 0.76
A GWAS SNP for Schizophrenia Is Linked to the Internal MIR137 Promoter and Supports Differential Allele-Specific Expression. Schizophr Bull (2015) 0.76
Epigenetic silencing of miR-137 contributes to early colorectal carcinogenesis by impaired Aurora-A inhibition. Oncotarget (2016) 0.75
Low Expression of Mir-137 Predicts Poor Prognosis in Cutaneous Melanoma Patients. Med Sci Monit (2016) 0.75
C-terminal binding proteins are essential pro-survival factors that undergo caspase-dependent downregulation during neuronal apoptosis. Mol Cell Neurosci (2013) 0.75
Role of microRNA508-3p in melanogenesis by targeting microphthalmia transcription factor in melanocytes of alpaca. Animal (2016) 0.75
Differential regulation of schizophrenia-associated microRNA gene function by variable number tandem repeats (VNTR) polymorphism. Schizophr Res (2013) 0.75
MiR-137: an important player in neural development and neoplastic transformation. Mol Psychiatry (2016) 0.75
MicroRNA-137 inhibits growth of glioblastoma through EGFR suppression. Am J Transl Res (2017) 0.75
miR-330-5p targets tyrosinase and induces depigmentation. J Invest Dermatol (2014) 0.75
Advances in the Application and Impact of MicroRNAs as Therapies for Skin Disease. BioDrugs (2017) 0.75
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet (2010) 9.90
Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma. J Clin Oncol (2012) 6.78
Bayesian inference analyses of the polygenic architecture of rheumatoid arthritis. Nat Genet (2012) 4.41
Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk. Nat Genet (2009) 3.52
A simple technique for quantifying apoptosis in 96-well plates. BMC Biotechnol (2005) 2.77
Contralesional repetitive transcranial magnetic stimulation for chronic hemiparesis in subcortical paediatric stroke: a randomised trial. Lancet Neurol (2008) 2.10
Multimodal imaging of brain reorganization in motor areas of the contralesional hemisphere of well recovered patients after capsular stroke. Brain (2005) 2.03
Short and long latency afferent inhibition in Parkinson's disease. Brain (2003) 2.02
The mechanisms of interhemispheric inhibition in the human motor cortex. J Physiol (2002) 1.92
Constraint-induced therapy in stroke: magnetic-stimulation motor maps and cerebral activation. Neurorehabil Neural Repair (2003) 1.83
Microphthalmia transcription factor as a molecular marker for circulating tumor cell detection in blood of melanoma patients. Clin Cancer Res (2006) 1.72
Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma. Blood (2008) 1.71
Effect of low-frequency repetitive transcranial magnetic stimulation on interhemispheric inhibition. J Neurophysiol (2005) 1.70
ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets. Stem Cells (2012) 1.70
Safety and efficacy of brentuximab vedotin for Hodgkin lymphoma recurring after allogeneic stem cell transplantation. Blood (2012) 1.67
Deep brain stimulation for Parkinson's disease: disrupting the disruption. Lancet Neurol (2002) 1.67
Absence of integrin αvβ3 enhances vascular leak in mice by inhibiting endothelial cortical actin formation. Am J Respir Crit Care Med (2012) 1.64
Exploring the connectivity between the cerebellum and motor cortex in humans. J Physiol (2004) 1.60
MicroRNA-26a is strongly downregulated in melanoma and induces cell death through repression of silencer of death domains (SODD). J Invest Dermatol (2012) 1.59
Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias. Brain (2006) 1.53
Long-term follow-up and survival of patients following a recurrence of melanoma after a negative sentinel lymph node biopsy result. JAMA Surg (2013) 1.50
N-Methyl-D-Aspartate antagonists in levodopa induced dyskinesia: a meta-analysis. Can J Neurol Sci (2012) 1.49
Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002. MMWR Recomm Rep (2002) 1.48
Myoclonus. Continuum (Minneap Minn) (2013) 1.47
Increased motor cortical facilitation and decreased inhibition in Parkinson disease. Neurology (2013) 1.47
Somatosensory evoked potentials recorded from the human pedunculopontine nucleus region. Mov Disord (2010) 1.46
Effective treatment of mouse sepsis with an inhibitory antibody targeting integrin αvβ5. Crit Care Med (2013) 1.44
Clinical Management Updates in Mantle Cell Lymphoma. Oncology (Williston Park) (2016) 1.43
Engraftment is optimal when myoblasts are transplanted early: the role of hepatocyte growth factor. Ann Thorac Surg (2010) 1.42
Hodgkin lymphoma, version 2.2012 featured updates to the NCCN guidelines. J Natl Compr Canc Netw (2012) 1.40
Evidence for impaired cortical inhibition in schizophrenia using transcranial magnetic stimulation. Arch Gen Psychiatry (2002) 1.39
Definition and classification of hyperkinetic movements in childhood. Mov Disord (2010) 1.38
Two phases of short-interval intracortical inhibition. Exp Brain Res (2003) 1.37
Serial monitoring of circulating melanoma cells during neoadjuvant biochemotherapy for stage III melanoma: outcome prediction in a multicenter trial. J Clin Oncol (2005) 1.37
Cortical and spinal abnormalities in psychogenic dystonia. Ann Neurol (2006) 1.31
Metastatic melanoma in the breast: a report of 27 cases. J Surg Oncol (2006) 1.31
A patient tumor transplant model of squamous cell cancer identifies PI3K inhibitors as candidate therapeutics in defined molecular bins. Mol Oncol (2013) 1.28
Rigidity and spasms from autoimmune encephalomyelopathies: stiff-person syndrome. Muscle Nerve (2006) 1.27
The modified bradykinesia rating scale for Parkinson's disease: reliability and comparison with kinematic measures. Mov Disord (2011) 1.27
Digit somatotopy within cortical areas of the postcentral gyrus in humans. Cereb Cortex (2008) 1.26
Rapid modulation of GABA in sensorimotor cortex induced by acute deafferentation. Ann Neurol (2002) 1.25
Evidence for impaired long-term potentiation in schizophrenia and its relationship to motor skill learning. Cereb Cortex (2007) 1.24
Effects of theta burst stimulation on motor cortex excitability in Parkinson's disease. Clin Neurophysiol (2011) 1.23
p53 prevents progression of nevi to melanoma predominantly through cell cycle regulation. Pigment Cell Melanoma Res (2010) 1.21
Effect of transcranial magnetic stimulation on Parkinson motor function--systematic review of controlled clinical trials. Mov Disord (2009) 1.20
Retreatment with brentuximab vedotin in patients with CD30-positive hematologic malignancies. J Hematol Oncol (2014) 1.18
RhoC promotes human melanoma invasion in a PI3K/Akt-dependent pathway. J Invest Dermatol (2006) 1.17
Cathepsin cleavage of sirtuin 1 in endothelial progenitor cells mediates stress-induced premature senescence. Am J Pathol (2012) 1.16
Involvement of the cerebellothalamocortical pathway in Parkinson disease. Ann Neurol (2010) 1.16
The effects of repetitive transcranial magnetic stimulation on cortical inhibition in healthy human subjects. Exp Brain Res (2006) 1.15
A global perspective on vaccine safety and public health: the Global Advisory Committee on Vaccine Safety. Am J Public Health (2004) 1.15
Depletion of cAMP-response element-binding protein/ATF1 inhibits adipogenic conversion of 3T3-L1 cells ectopically expressing CCAAT/enhancer-binding protein (C/EBP) alpha, C/EBP beta, or PPAR gamma 2. J Biol Chem (2006) 1.15
Intensity-dependent effects of 1 Hz rTMS on human corticospinal excitability. Clin Neurophysiol (2002) 1.15
Evidence for gamma inhibition deficits in the dorsolateral prefrontal cortex of patients with schizophrenia. Brain (2010) 1.14
Cerebral blood flow changes induced by pedunculopontine nucleus stimulation in patients with advanced Parkinson's disease: a [(15)O] H2O PET study. Hum Brain Mapp (2009) 1.13
Dystonia in complex regional pain syndrome type I. Ann Neurol (2010) 1.13
Long-interval cortical inhibition from the dorsolateral prefrontal cortex: a TMS-EEG study. Neuropsychopharmacology (2008) 1.12
Platelet-derived growth factor BB induces nuclear export and proteasomal degradation of CREB via phosphatidylinositol 3-kinase/Akt signaling in pulmonary artery smooth muscle cells. Mol Cell Biol (2006) 1.12
The role of the corpus callosum in transcranial magnetic stimulation induced interhemispheric signal propagation. Biol Psychiatry (2010) 1.12
Impairments of speed and amplitude of movement in Parkinson's disease: a pilot study. Mov Disord (2009) 1.12
The effects of inhibitory and facilitatory intracortical circuits on interhemispheric inhibition in the human motor cortex. J Physiol (2007) 1.12
Side population cells from human melanoma tumors reveal diverse mechanisms for chemoresistance. J Invest Dermatol (2012) 1.12
Unilateral subdural motor cortex stimulation improves essential tremor but not Parkinson's disease. Brain (2011) 1.11
The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI). Vaccine (2002) 1.11
Severe paraneoplastic hypoglycemia in a patient with a gastrointestinal stromal tumor with an exon 9 mutation: a case report. BMC Cancer (2007) 1.11
Dysfunctional neural plasticity in patients with schizophrenia. Arch Gen Psychiatry (2008) 1.10
A phase II study of the heparanase inhibitor PI-88 in patients with advanced melanoma. Invest New Drugs (2007) 1.09
Deep brain stimulation of the ventral intermediate nucleus of the thalamus in medically refractory orthostatic tremor: preliminary observations. Mov Disord (2008) 1.09
Differential response of speed, amplitude, and rhythm to dopaminergic medications in Parkinson's disease. Mov Disord (2011) 1.09
Cortical excitability and interhemispheric inhibition after subcortical pediatric stroke: plastic organization and effects of rTMS. Clin Neurophysiol (2010) 1.09
Two phases of interhemispheric inhibition between motor related cortical areas and the primary motor cortex in human. Cereb Cortex (2008) 1.09
Transcranial magnetic stimulation in different current directions activates separate cortical circuits. J Neurophysiol (2010) 1.08
The nature and time course of cortical activation following subthalamic stimulation in Parkinson's disease. Cereb Cortex (2009) 1.08
Safety of the trivalent inactivated influenza vaccine among children: a population-based study. Arch Pediatr Adolesc Med (2004) 1.08
BH3 mimetic ABT-737 and a proteasome inhibitor synergistically kill melanomas through Noxa-dependent apoptosis. J Invest Dermatol (2008) 1.07
Combined scalp-thalamic EEG recording in sleep and epilepsy. Clin Neurophysiol (2002) 1.07
Reduced cerebellar inhibition in schizophrenia: a preliminary study. Am J Psychiatry (2005) 1.05
Interactions between long latency afferent inhibition and interhemispheric inhibitions in the human motor cortex. J Physiol (2005) 1.05
Potentiation of gamma oscillatory activity through repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex. Neuropsychopharmacology (2009) 1.05
Interhemispheric inhibition in distal and proximal arm representations in the primary motor cortex. J Neurophysiol (2007) 1.04
Phase II multicenter study of neoadjuvant biochemotherapy for patients with stage III malignant melanoma. J Clin Oncol (2006) 1.03
rTMS for suppressing neuropathic pain: a meta-analysis. J Pain (2009) 1.03
Effects of peripheral sensory input on cortical inhibition in humans. J Physiol (2002) 1.03
Neurocardiogenic syncope complicating pediatric transcranial magnetic stimulation. Pediatr Neurol (2008) 1.02
Functional proteomic analysis of melanoma progression. Cancer Res (2003) 1.02
Expanding the phenomenology of benign hereditary chorea: evolution from chorea to myoclonus and dystonia. Mov Disord (2011) 1.01
Commotio cordis and ventricular pseudoaneurysm. Can J Cardiol (2009) 1.01
Digit-specific aberrations in the primary somatosensory cortex in Writer's cramp. Ann Neurol (2009) 1.01
Short interval intracortical inhibition and facilitation during the silent period in human. J Physiol (2007) 1.00
Transcranial magnetic stimulation: a new investigational and treatment tool in psychiatry. J Neuropsychiatry Clin Neurosci (2002) 1.00
The role of the cerebellum in the pathophysiology and treatment of neuropsychiatric disorders: a review. Brain Res Rev (2008) 0.99
Interhemispheric and ipsilateral connections in Parkinson's disease: relation to mirror movements. Mov Disord (2007) 0.99
Gastrointestinal melanoma or clear cell sarcoma? Molecular evaluation of 7 cases previously diagnosed as malignant melanoma. Am J Surg Pathol (2008) 0.98
Involvement of the basal ganglia and cerebellar motor pathways in the preparation of self-initiated and externally triggered movements in humans. J Neurosci (2007) 0.98
Movement related potentials and oscillatory activities in the human internal globus pallidus during voluntary movements. J Neurol Neurosurg Psychiatry (2011) 0.98